Related Experiment Video
Updated: May 29, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Augmented therapeutic efficacy of irinotecan is associated with enhanced drug accumulation
Rami G Azrak1, Shousong Cao, Farukh A Durrani
1Department of Cancer Biology, Roswell Park Cancer Institute, Buffalo, NY 14263, United States. Azrak@roswellpark.org
Abstract:
The goal of this study is to determine whether treatment with methylselenocysteine (MSC) results in differential uptake of irinotecan and its active metabolite (SN-38) between tumors of head and neck squamous cell carcinomas and normal tissue. The in vivo synergy between MSC and irinotecan is influenced by treatment schedule and associated with enhancement of tumor vessel maturation, intra-tumor concentration of SN-38 and apoptotic death of tumor cells. Normal tissue drug concentrations were not impacted by selenium treatment. The finding is of clinical relevance for enabling the delivery of higher doses of irinotecan to reverse tumor resistance, recurrence and ultimately enhancing cure rates.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug Distribution: Tissue Binding
For...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug toxicity: Drug–Drug Interaction
